IGF-1 Receptor α/IGF1R Antibody (16-13): sc-80985

IGF-IRα Antibody (16-13) is a mouse monoclonal IgG2b antibody that detects insulin-like growth factor-I receptor (IGF-IR) in human samples through immunoprecipitation (IP). IGF-IR plays a crucial role in cellular signaling pathways that regulate growth, survival, and differentiation, making IGF-IR a significant player in various physiological processes and disease states, including cancer. IGF-IR is primarily located on the cell membrane, where IGF-IR acts as a transmembrane molecular scaffold that facilitates the binding of insulin-like growth factor-I (IGF-I). This interaction triggers a cascade of intracellular signaling events, including the activation of the Ras and ERK pathways, which ultimately influence gene expression and cellular behavior. IGF-IR′s membrane-bound position allows for rapid response to extracellular signals, thereby modulating critical cellular functions. The human IGF-IR gene, located on chromosome 15q26.3, encodes a precursor protein that is cleaved into α and β subunits, further emphasizing the complexity and regulatory mechanisms involved in IGF-IR function. Through interactions with various adaptor proteins, IGF-IR initiates downstream signaling essential for maintaining cellular homeostasis and responding to growth factors, making anti-IGF-IRα antibody (16-13) a valuable tool for researchers studying these vital processes.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

IGF-1 Receptor α/IGF1R Antibody (16-13) References:

1. Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha.  |  Brockdorff, BL., et al. 2003. Endocr Relat Cancer. 10: 579-90. PMID: 14713268
2. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.  |  Ray, A., et al. 2007. Int J Oncol. 30: 1499-509. PMID: 17487372
3. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.  |  Zhang, Y. and Zhang, Y. 2008. Cancer Invest. 26: 230-6. PMID: 18317963
4. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.  |  Rogozina, OP., et al. 2009. Cancer Prev Res (Phila). 2: 712-9. PMID: 19654106
5. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.  |  Yue, L., et al. 2012. Oncol Rep. 28: 1453-60. PMID: 22895605
6. Expression and possible role of IGF-IR in the mouse gastric myenteric plexus and smooth muscles.  |  Zhang, GQ., et al. 2014. Acta Histochem. 116: 788-94. PMID: 24630395
7. Expression of Cell Surface Receptors on Human Glioblastoma Xenograft Model in NOD/SCID Mouse.  |  Oh, KS., et al. 2002. Cancer Res Treat. 34: 52-7. PMID: 26680843
8. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.  |  Elbaz, M., et al. 2017. Oncotarget. 8: 29668-29678. PMID: 27213582
9. The complete salmonid IGF-IR gene repertoire and its transcriptional response to disease.  |  Alzaid, A., et al. 2016. Sci Rep. 6: 34806. PMID: 27748369
10. Regulation of IGF-I by IGFBP3 and IGFBP5 during odontoblast differentiation in mice.  |  Aizawa, C., et al. 2019. J Oral Biosci. 61: 157-162. PMID: 31400542

The preferred IGF-1 Receptor α/IGF1R antibody is IGF-1 Receptor α/IGF1R Antibody (2C8): sc-463.